Inherited Metabolic Diseases and Cardiac Pathology in Adults: Diagnosis and Prevalence in a CardioMetabo Study
Open Access
- 3 March 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (3), 694
- https://doi.org/10.3390/jcm9030694
Abstract
Many inherited metabolic diseases (IMD) have cardiac manifestations. The aim of this study was to estimate the prevalence of IMD in adult patients with hypertrophic cardiomyopathy (HCM) and cardiac rhythm abnormalities that require cardiac implantable electronic devices (CIEDs). The study included a review of the medical files of patients aged 18 to 65 years who were followed in our cardiology department during the period 2010–2017. Metabolic explorations for Fabry disease (FD), mitochondrial cytopathies, and fatty-acid metabolism disorders were carried out in patients with unexplained etiology. The prevalence of IMD in patients with HCM was 5.6% (confidence interval (CI): 2.6–11.6). Six cases of IMD were identified: 1 mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome, 1 Hurler syndrome, 2 Friedreich’s ataxia, 1 FD, and 1 short-chain acyl-CoA dehydrogenase deficiency. Three cases of IMD were identified in patients requiring CIEDs: 1 patient with Leber hereditary optic neuropathy, 1 FD, and 1 short chain acyl-CoA dehydrogenase (SCAD) deficiency. IMD prevalence in patients with CIEDs was 3.1% (CI: 1.1–8.8). IMD evaluation should be performed in unexplained HCM and cardiac rhythm abnormalities adult patients, since the prevalence of IMD is relatively important and they could benefit from specific treatment and family diagnosis.This publication has 36 references indexed in Scilit:
- Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and managementEuropean Heart Journal, 2012
- Déficit en acyl-CoA-déshydrogénase des acides gras à chaîne moyenne (MCAD) : consensus français pour le dépistage, le diagnostic, et la prise en chargeArchives de Pédiatrie, 2012
- Manifestations cardiaques de la maladie de Fabry et données d’efficacité de l’enzymothérapieLa Revue de Médecine Interne, 2010
- Place de la maladie de Fabry au sein des cardiomyopathies hypertrophiques d’origine génétiqueLa Revue de Médecine Interne, 2010
- Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS studyHeart, 2010
- The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened populationJournal of Inherited Metabolic Disease, 2010
- Clinical aspects of short‐chain acyl‐CoA dehydrogenase deficiencyJournal of Inherited Metabolic Disease, 2010
- Mitochondrial fatty acid oxidation defects—remaining challengesJournal of Inherited Metabolic Disease, 2008
- High incidence of pre‐excitation syndrome in Japanese families with Leber's hereditary optic neuropathyClinical Genetics, 1996
- Pre-excitation syndrome in Leber's hereditary optic neuropathyThe Lancet, 1994